Back to Search Start Over

Correlation of ACR TI-RADS and Patient Outcomes in a Real-World Cohort Presenting for Thyroid Ultrasonography.

Authors :
Wilkinson T
Cawood T
Lim A
Roche D
Jiang J
Thomson B
Marais M
Hunt P
Source :
Journal of the Endocrine Society [J Endocr Soc] 2023 Sep 19; Vol. 7 (10), pp. bvad119. Date of Electronic Publication: 2023 Sep 19 (Print Publication: 2023).
Publication Year :
2023

Abstract

Context: The American College of Radiology Thyroid Image Reporting and Data System (ACR TI-RADS) was developed to predict malignancy risk in thyroid nodules using ultrasound features. TI-RADS was derived from a database of patients already selected for fine-needle aspiration (FNA), raising uncertainty about applicability to unselected patients.<br />Objective: We aimed to assess the effect of ACR TI-RADS reporting in unselected patients presenting for thyroid ultrasound in a real-world setting.<br />Methods: Records for all patients presenting for thyroid ultrasonography in Canterbury, New Zealand, were reviewed across two 18-month periods, prior to and after implementation of TI-RADS reporting. Patient outcomes were compared between the 2 periods. Malignancy rates were calculated for nodules 10 mm or larger with a definitive FNA or histology result.<br />Results: A total of 1210 nodules were identified in 582 patients prior to implementation of TI-RADS; 1253 nodules were identified in 625 patients after implementation of TI-RADS. TI-RADS category was associated with malignancy rate (0% in TR1 and TR2, 3% in TR3, 5% in TR4, 12% in TR5; P = .02); however, 63% of nodules were graded TR3 or TR4, for which malignancy rate did not meaningfully differ from baseline risk. After implementation of TI-RADS there was a small reduction in the proportion of patients proceeding to FNA (49% vs 60%; P < .01) or surgery (14% vs 18%; P < .05), with no difference in cancer diagnoses (3% vs 4%, not significant).<br />Conclusion: TI-RADS category is associated with malignancy rate and may alter clinical decision-making in a minority of patients; however, it is nondiscriminatory in the majority of nodules. In this study of unselected patients, nodules classified as TR5 and thus considered "highly suspicious" for cancer had only a modest risk of malignancy.<br /> (© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society.)

Details

Language :
English
ISSN :
2472-1972
Volume :
7
Issue :
10
Database :
MEDLINE
Journal :
Journal of the Endocrine Society
Publication Type :
Academic Journal
Accession number :
37795193
Full Text :
https://doi.org/10.1210/jendso/bvad119